BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2524394)

  • 1. Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs.
    Stewart BR; Jenner P; Marsden CD
    Eur J Pharmacol; 1989 Mar; 162(1):101-7. PubMed ID: 2524394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.
    Freo U; Holloway HW; Greig NH; Soncrant TT
    Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors.
    Gudelsky GA; Koenig JI; Meltzer HY
    Neuropharmacology; 1986 Dec; 25(12):1307-13. PubMed ID: 2951611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothermia induced by m-trifluoromethylphenylpiperazine or m-chlorophenylpiperazine: an effect mediated by 5-HT1B receptors?
    Maj J; Chojnacka-Wójcik E; Kłodzińska A; Dereń A; Moryl E
    J Neural Transm; 1988; 73(1):43-55. PubMed ID: 2969949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory.
    Winter JC; Petti DT
    Pharmacol Biochem Behav; 1987 Aug; 27(4):625-8. PubMed ID: 2958885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum.
    Bonanno G; Maura G; Raiteri M
    Eur J Pharmacol; 1986 Jul; 126(3):317-21. PubMed ID: 2944750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
    Cunningham KA; Appel JB
    J Pharmacol Exp Ther; 1986 May; 237(2):369-77. PubMed ID: 2939233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
    Parsons AA; Motevalian M; Whalley ET
    Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat.
    Stewart BR; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1988; 96(1):55-62. PubMed ID: 2906443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats.
    Nanry KP; Tilson HA
    Psychopharmacology (Berl); 1989; 97(4):507-13. PubMed ID: 2524858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA; Ageel AM; Ginawi OT
    Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Goodwin GM; De Souza RJ; Green AR; Heal DJ
    Psychopharmacology (Berl); 1987; 91(4):506-11. PubMed ID: 2954179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
    Smith LM; Peroutka SJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1513-9. PubMed ID: 2942947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.